BIRC5 and neoplasm: On the other hand, Freier et al. found no statistical difference between tumours with a gain in BIRC5 gene copy number and those with a balanced BIRC5 locus (P > .05) in terms of the prevalence of high survivin expression, and high survivin expression predicted longer OS in a subgroup of patients with advanced tumours treated by radiotherapy [138].